An in vivo model of allergic inflammation: pulmonary human cell infiltrate in allergen-challenged allergic Hu-SCID mice.
CB.17 severe combined immunodeficient (SCID) mice were used to establish a model of allergic pulmonary inflammation. SCID mice were intraperitoneally reconstituted with 10(7) peripheral blood mononuclear cells (PBMC) from patients sensitive to Dermatophagoides pteronyssinus (Dpt) and 2 weeks later were exposed to Dpt aerosols. After Dpt nebulization, SCID mice engrafted with PBMC from Dpt-sensitive patients developed a specific human IgE response as well as an intense pulmonary infiltrate of human cells. In contrast, SCID mice reconstituted with PBMC from patients allergic to grass pollen or from non-allergic donors failed to produce IgE or to exhibit a similar inflammatory response. The level of the IgE production was dependent on the IgE level of the allergic donor. In the lungs of the same allergic SCID mice, 2 months after Dpt inhalation, the cell infiltrate contained CD45+, CD45RO+, CD20+ and HLA-DR+ human cells. They were located in perivascular and peribronchial areas and disseminated in the mouse lung parenchyma. Moreover, mRNA IL-5+ cells and eosinophils were found in peribronchial infiltrates. The observations indicate that humanized allergic SCID mice may develop, after nebulization with the relevant allergen, immune reactions similar to those observed in man and suggest that SCID mice may represent a useful model to analyze the regulatory mechanisms of IgE-associated allergic diseases.
Duez
C
C
INSERM U416, Institut Pasteur, Lille, France.
Tsicopoulos
A
A
Janin
A
A
Tillie-Leblond
I
I
Thyphronitis
G
G
Marquillies
P
P
Hamid
Q
Q
Wallaert
B
B
Tonnel
A B
AB
Pestel
J
J
D000280:Administration, Inhalation; D000336:Aerosols; D000485:Allergens / Q000008:administration & dosage*; D000818:Animals; D039741:Antigens, Dermatophagoides; D002465:Cell Movement / Q000276:immunology*; D004195:Disease Models, Animal; D004804:Eosinophils / Q000473:pathology; D006023:Glycoproteins / Q000008:administration & dosage; D006801:Humans; D007073:Immunoglobulin E / Q000096:biosynthesis; D007249:Inflammation / Q000276:immunology / Q000473:pathology*; D015848:Interleukin-5 / Q000235:genetics; D007963:Leukocytes, Mononuclear / Q000637:transplantation; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D016513:Mice, SCID; D008925:Mites / Q000276:immunology; D012333:RNA, Messenger / Q000096:biosynthesis; D012130:Respiratory Hypersensitivity / Q000276:immunology / Q000473:pathology*
D000336:Aerosols; D000485:Allergens; D039741:Antigens, Dermatophagoides; D006023:Glycoproteins; D015848:Interleukin-5; D012333:RNA, Messenger; D007073:Immunoglobulin E